Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff
Clinical trial NCT03110133 · COMPLETED
Trial details
- NCT number
- NCT03110133
- Sponsor
- Finch Research and Development LLC.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-08
- Primary completion
- 2020-02-28
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.